Home / Phase III trial on nadofaragene firadenovec for high-grade, BCG unresponsive NMIBC patients
Phase III trial on nadofaragene firadenovec for high-grade, BCG unresponsive NMIBC patients
This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
